Peptide PT-141 para que sirve means what PT-141 is used for: an FDA-approved peptide for low sexual desire in women, used off-label by U.S. men.
PT-141 (bremelanotide) is a synthetic peptide used to treat low sexual desire. The U.S. Food and Drug Administration approved it in 2019 under the brand name Vyleesi for premenopausal women with hypoactive sexual desire disorder, and men use it off-label. The question behind “péptido pt-141 para que sirve” has a short answer: this peptide targets desire signaling in the brain, not blood flow to the genitals.
What PT-141 Is Used For
PT-141 is a melanocortin receptor agonist that mimics alpha-melanocyte-stimulating hormone, a natural compound involved in arousal and appetite. It was first studied as a tanning agent before researchers noticed its effect on sexual desire.
- Approved use: Hypoactive sexual desire disorder (HSDD) in premenopausal women, sold as Vyleesi.
- Off-label use: Low libido in men. Many people search for pt-141 peptide for men after PDE5 inhibitors such as sildenafil failed to improve their interest in sex.
- Research interest: Sexual dysfunction linked to SSRI antidepressants, menopause, and diabetes.
- Not approved for: Erectile dysfunction, even though early clinical trials tested it for that purpose.
PT-141 is not a hormone, and it does not raise testosterone. It also is not a treatment for physical causes of erectile problems, such as narrowed arteries or nerve damage.
How PT-141 Works in the Body
PT-141 binds mainly to MC4R receptors in the hypothalamus, the brain region that regulates motivation, mood, and appetite. That mechanism is why it is often described as a desire peptide rather than a performance drug.
Because PT-141 acts on the brain, it can increase sexual interest even when blood flow and hormone levels are normal. PDE5 inhibitors work on blood vessels and typically do nothing for libido on their own.
PT-141 and PDE5 inhibitors target different systems, and the FDA has not approved combining them.
Injection vs. Nasal Spray
The FDA-approved version of PT-141 is a subcutaneous injection. A compounded pt-141 peptide nasal spray is sold by some online vendors, but no nasal form has been approved for human use in the United States.
| Form | Typical dose | Onset | Duration | Status |
|---|---|---|---|---|
| Subcutaneous injection | 1.75 mg | About 45 minutes | A few hours | FDA-approved (Vyleesi) |
| Nasal spray | Not standardized | 15–45 minutes | Shorter than injection | Not FDA-approved |
Nasal absorption is inconsistent, so users report widely different results. Injection allows a more predictable dose, which matters because PT-141 raises blood pressure.
Typical PT-141 Dosing
The approved dose is 1.75 mg injected under the skin at least 45 minutes before anticipated sexual activity. It should not be used more than once in 24 hours or more than eight times per month.
| Context | Dose | Route | Frequency limit |
|---|---|---|---|
| Premenopausal women (approved label) | 1.75 mg | Subcutaneous injection | Once per 24 hours, maximum 8 doses per month |
| Men (off-label, research reports) | 1–2 mg | Subcutaneous injection | Not established; mostly single doses studied |
| Nasal spray (unapproved) | Not standardized | Intranasal | Not established |
The details above describe the approved label and published research; they are not a recommendation to self-dose. A pt-141 peptide dosage chart shared on forums is not a substitute for medical guidance, and anyone researching pt-141 peptide dosage for men should know that no large FDA-reviewed trial has established a safe male dose.
Side Effects and Safety
Nausea is the most common side effect, reported by roughly 40% of participants in the trials that led to approval. Other reported effects include flushing, headache, vomiting, injection-site reactions, and darkening of the gums or skin with frequent use.
PT-141 temporarily raises blood pressure for several hours after each dose. It is contraindicated for people with uncontrolled high blood pressure or known cardiovascular disease.
- PT-141 is not recommended during pregnancy or breastfeeding.
- Alcohol can worsen nausea and blood pressure changes.
- Focal hyperpigmentation may appear after repeated use, especially on the face and gums.
Anyone considering PT-141 should talk with a licensed healthcare professional, particularly if they take blood pressure medication or have a heart condition.
Legal Status and Where People Find It
PT-141 is a prescription-only medicine in the United States. Buying it without a prescription usually means buying a research chemical or an unregulated compounded product, which is not the same thing as the approved drug.
Vials labeled “for research use only” are not manufactured under FDA oversight for human use, so purity and actual peptide content can vary. Searches for lipo c nitina para que sirve point to a different category of injectables — lipotropic and vitamin blends — and those products have nothing to do with PT-141's effect on desire.
Legitimate access runs through a physician, a telehealth prescriber, or a specialty pharmacy that dispenses Vyleesi. Compounded versions exist, but they are not FDA-approved.
PT-141 is a real prescription drug for low sexual desire, but it is not a cure for sexual dysfunction and it carries cardiovascular risks that require medical screening first.
Frequently Asked Questions
What is the peptide PT-141 used for?
PT-141 is used to increase sexual desire. It is FDA-approved as bremelanotide (Vyleesi) for premenopausal women with hypoactive sexual desire disorder, and it is used off-label by men. It works through melanocortin receptors in the brain rather than through blood flow.
Is PT-141 FDA-approved for men?
No. The FDA approved PT-141 only for premenopausal women with hypoactive sexual desire disorder, sold as Vyleesi. Men use it off-label, and no approved male dose exists. Anyone considering it should be screened for high blood pressure and heart disease first.
How long does PT-141 take to work?
The approved label directs patients to inject at least 45 minutes before anticipated sexual activity. Effects on desire are generally reported within an hour and can last several hours. Nasal spray versions may act faster, but they are not FDA-approved and absorb inconsistently.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.